The stock market operates in cycles, shifting between periods of upward, downward and sideways trends. For investors, recognizing when these trends change is important to assess the sale or hold of ...

Discover how secular trends drive stock investments and how to identify long-term opportunities. Explore examples, including ...

Electric vehicles (EVs) are an essential part of the transition to a cleaner, greener economy. EVs are also a key driver of demand for battery metals, such as lithium, cobalt, graphite, nickel and ...

Market trends are strong engines of creativity, expansion and financial success. They give businesses and entrepreneurs windows of opportunity to establish their brands and gain traction and a ...

Forbes contributors publish independent expert analyses and insights. Claudia Alarcón covers food, drinks and travel in places near and far. The Whole Foods Market Trends Council, comprised of more ...

A bull market occurs when stocks are rising, the economy is expanding, and there is overall optimism towards market conditions. On the contrary, a bear market occurs when stock prices are falling, the ...

Market change refers to the dynamic and continual evolution of marketplaces due to a variety of factors. Those factors include: Technological Advancements: Innovations in technology can rapidly alter ...

Utilizing market research to inform decision-making begins with clearly identifying the objective: What specific goal am I looking to achieve? The scope and nature of the decision to be made will ...

Learn how to make sense of key crypto metrics—so you can read the market, not just watch the price. Meagan is a former Series 7 financial advisor and current writer focused on blending straightforward ...

Faceless avatars chime in with a standard missive. “Gnoise,” they say—a riff on “gm” or “gmorning,” which is internet parlance for greeting a new day. Noise’s fandom seems to be thriving, at least for ...

Oncology, ophthalmology, and pegfilgrastim biosimilars reached 81% market share within five years, while others lagged at 26%. CMS increased biosimilar reimbursement to ASP plus 8% of the originator's ...